Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets.
[familial hypocalciuric hypercalcemia]
Heterozygous
inactivating
calcium-sensing
receptor
(
CaSR
)
mutations
lead
to
familial
hypocalciuric
hypercalcemia
(
FHH
)
,
whereas
homozygous
mutations
usually
cause
neonatal
severe
hyperparathyroidism
.
The
objective
of
the
study
was
to
investigate
the
pathophysiological
mechanisms
of
a
homozygous
inactivating
CaSR
mutation
identified
in
a
16
-
year
-old
female
.
Clinical
,
biochemical
,
and
genetic
analyses
of
the
index
patient
and
her
family
were
performed
.
Functional
capacity
of
CaSRQ
459
R
and
CaSR
mutants
causing
FHH
(
Q
27
R
,
P
39
A
,
S
417
C
)
or
neonatal
severe
hyperparathyroidism
(
W
718
X
)
was
assessed
.
Activation
of
the
cytosolic
calcium
pathway
and
inhibition
of
PTH
-induced
cAMP
signaling
were
measured
.
A
16
-
year
-old
girl
presented
with
adolescent
rickets
,
vitamin
D
deficiency
,
and
secondary
hyperparathyroidism
.
Vitamin
D
treatment
unmasked
features
resembling
FHH
,
and
genetic
testing
revealed
a
homozygous
CaSRQ
459
R
mutation
.
Two
apparently
healthy
siblings
were
homozygous
for
CaSRQ
459
R
and
had
asymptomatic
hypercalcemia
and
hypocalciuria
.
The
CaSRQ
459
R
mutation
leads
to
mild
functional
inactivation
in
vitro
,
which
explains
the
FHH
-like
phenotype
in
homozygous
family
members
and
the
grossly
exaggerated
PTH
response
to
vitamin
D
deficiency
in
the
index
case
.
The
patient
's
parents
and
two
other
siblings
were
heterozygous
,
had
normal
serum
calcium
and
PTH
,
but
had
marked
hypocalciuria
,
which
appeared
to
be
associated
with
impaired
in
vitro
activation
of
the
calcium
signaling
pathway
by
CaSRQ
459
R
.
The
Q
459
R
mutation
responded
well
to
calcimimetic
treatment
in
vitro
.
CaSR
mutations
causing
mild
functional
impairment
can
lead
to
FHH
,
even
in
homozygous
patients
.
The
skeletal
deformities
in
the
index
case
were
mainly
due
to
severe
vitamin
D
deficiency
,
and
the
CaSR
mutation
did
not
appear
to
have
played
a
major
independent
role
in
the
skeletal
phenotype
.
Diseases
Validation
Diseases presenting
"severe hyperparathyroidism"
symptom
familial hypocalciuric hypercalcemia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom